Advocacy intelligence hub — real-time data for patient organizations
Menzies School of Health Research — PHASE3
University of Oxford — PHASE4
European Vaccine Initiative — PHASE1
National Institute of Allergy and Infectious Diseases (NIAID) — PHASE2
Malaria Vaccine and Drug Development Center — PHASE2
Serum Institute of India Pvt. Ltd. — PHASE2
GlaxoSmithKline — PHASE2
National Institute of Allergy and Infectious Diseases (NIAID) — PHASE1
University of Oxford — PHASE1, PHASE2
University of California, San Francisco — NA
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance2
Sarah G Staedke, MD
London School of Hygiene and Tropical Medicine
Arjen Dondorp, MD
Mahidol Oxford Tropical Medicine Research Unit, Bangkok, Thailand
Sunil Parikh, MD MPH, MD., MPH
Yale University
📍 WEST PALM BEACH, FL
Katherine Plewes, MD
Mahidol Oxford Tropical Medicine Research Unit, Bangkok, Thailand
Pedro Aide, MD, MSc, PhD
pedro.aide@manhica.net
Benoit GAMAIN, Dr
Institut National de la Santé Et de la Recherche Médicale, France